An Amgen sign is seen at the company's office in South San Francisco. Photo: Reuters

Drug makers Astellas Pharma and Amgen to pay US$125 million in US charity kickback probe, as both deny wrongdoing

  • Investigation, led by the US Attorney’s Office in Boston, has been looking into drug makers’ financial support of patient assistance charities
Topic |   Pharmaceuticals

TOP PICKS

An Amgen sign is seen at the company's office in South San Francisco. Photo: Reuters
READ FULL ARTICLE
Hong Kong’s Department of Health recalled the antihypertensive drug Valtensin (80mg tablets and 160mg tablets, containing the active drug ingredient valsartan)) in July 2018 after traces of the carcinogen N-nitrosodimethylamine (NDMA) was found. Photo shows Valtensin (80mg tablets). Photo: ISD

A wave of lawsuits awaits 40 producers of valsartan, the popular heart drug tainted with the carcinogen NDMA

  • Zhejiang Huahai Pharmaceutical is among the 40 defendants, along with Teva Pharmaceutical Industries, Mylan and CVS Health, being sued
  • The US Food and Drug Administration is overseeing a recall of valsartan, used for treating high blood pressure and heart failure, after finding traces of the carcinogen NDMA in the drug
Topic |   China food safety

TOP PICKS

Hong Kong’s Department of Health recalled the antihypertensive drug Valtensin (80mg tablets and 160mg tablets, containing the active drug ingredient valsartan)) in July 2018 after traces of the carcinogen N-nitrosodimethylamine (NDMA) was found. Photo shows Valtensin (80mg tablets). Photo: ISD
READ FULL ARTICLE